Pfenex is a clinical-stage development and licensing biotechnology company focused on leveraging Pfēnex Expression Technology® to improve protein therapies for unmet patient needs. Using our Pfēnex Expression Technology platform, we have an established pipeline of wholly owned and partnered therapeutic equivalents, vaccines, biologics and biosimilars. We are currently seeking co-development partners where our protein production technology is uniquely enabling.  Additionally, Pfenex is the leading supplier of pre-clinical and clinical grade carrier protein CRM197 to the vaccine and immunotherapy community. Pfenex is the only fully integrated CRM197 carrier protein provider with captive capacity to support any clinical or commercial stage product.


Sign Up for Event Updates

Get Involved At World Vaccine Congress Washington


To Sponsor Or Exhibit

Marc Rhys-Evans
+44 20 7827 5945




To Register

Tayyab Abbasi
+44 20 7092 1210




Press Relations

Karina Kusova
+44 20 7092 1071